Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 141,900 shares, a growth of 27.2% from the January 15th total of 111,600 shares. Approximately 11.4% of the company’s stock are short sold. Based on an average daily trading volume, of 401,600 shares, the short-interest ratio is presently 0.4 days.

Autonomix Medical Stock Down 1.7 %

Shares of NASDAQ:AMIX traded down $0.05 on Friday, reaching $2.80. The company had a trading volume of 5,157 shares, compared to its average volume of 257,441. Autonomix Medical has a twelve month low of $2.55 and a twelve month high of $99.60. The stock has a 50-day moving average price of $3.12 and a 200 day moving average price of $9.05. The stock has a market capitalization of $3.22 million and a P/E ratio of -0.17. The company has a quick ratio of 4.26, a current ratio of 4.26 and a debt-to-equity ratio of 0.36.

Autonomix Medical (NASDAQ:AMIX) last posted its quarterly earnings data on Thursday, February 13th. The company reported ($1.46) EPS for the quarter. On average, equities analysts expect that Autonomix Medical will post -10 EPS for the current year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.